工程时间控制免疫疗法

Emanuel Salazar-Cavazos1, Grégoire Altan-Bonnet1

  • 1Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.

Science (New York, N.Y.)
|December 15, 2022
PubMed
概括

设计性淋巴细胞提供了治疗疾病的新途径, 这些工程免疫细胞对未来的治疗应用具有重大前景.